| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Puma Biotechnology, Inc.'s insiders have reduced their positions by a net 44,058 shares worth roughly $364K.
PBYI sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 7.26M | $64.70M | - | |
| CFO | 240.0K | $2.14M | - | |
| Other | 205.3K | $1.83M | - | |
| Dir | 54.0K | $481.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2020 | Hunt Douglas M62 | See Remarks | Sell | 572 | $10.69 | $6,111.82 | -1.0% | |
| Jul 2, 2020 | Bryce Richard Paul | See Remarks | Sell | 660 | $10.67 | $7,040.42 | -0.8% | |
| Jul 2, 2020 | Auerbach Alan H62 | President And CEO | Sell | 2,607 | $10.66 | $27,802.61 | - | |
| Jun 16, 2020 | Moyes Jay M49 | Director | Sell | 9,720 | $9.50 | $92,340.00 | -19.1% | |
| Jun 11, 2020 | Senderowicz Adrian48 | Director | Sell | 10,000 | $9.89 | $98,878.00 | -19.6% | |
| Jun 11, 2020 | Wilson Troy Edward64 | Director | Sell | 25,245 | $9.97 | $251,692.65 | -49.2% | |
| Jun 2, 2020 | Bryce Richard Paul | See Remarks | Sell | 89 | $10.66 | $948.74 | -0.1% | |
| Jun 2, 2020 | Auerbach Alan H62 | President And CEO | Sell | 342 | $10.71 | $3,661.92 | - | |
| May 4, 2020 | Bryce Richard Paul | See Remarks | Sell | 89 | $9.62 | $856.19 | -0.1% | |
| May 4, 2020 | Auerbach Alan H62 | President And CEO | Sell | 339 | $9.70 | $3,288.71 | - |